SCHEMBL8887381

SCHEMBL8887381

OC1CC(c2ccc(F)cc2)c2cc(Cl)ccc21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8887343 0.90 MAP3K14 (0.41)
SCHEMBL8887058 0.84 TRPM4 (0.48)
SCHEMBL8887938 0.84 TRPM5 (0.44)
SCHEMBL8887332 0.84
SCHEMBL8885782 0.83 DRD2 (0.46)
SCHEMBL5709363 0.82 SLC6A2 (0.37)
SCHEMBL5709356 0.81
SCHEMBL7320995 0.81
SCHEMBL8886689 0.81 SLC6A2 (0.50)
SCHEMBL27680712 0.79 TRPM5 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5643784-A TREATMENT OF ANXIETY, DEPRESSION, SLEEPING DISORDERS, SCHIZOPHRENIA AND MIGRAINE H, LUNDBECK A/S (DK) 1997-07-01 US disclosed
EP-0560868-B1 INDAN DERIVATIVES LUNDBECK & CO AS H (DK) 1995-04-19 EP disclosed
EP-0560868-A1 INDAN DERIVATIVES. LUNDBECK & CO AS H (DK) 1993-09-22 EP disclosed
WO-1992010192-A1 INDAN DERIVATIVES H. LUNDBECK A/S (DK) 1992-06-25 WO disclosed